Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Using 400% profits from POS and 100% RST I've added at 1.97p amd intended to add substantial more here and FCS
Good luck buying at 1.9p or in fact when news lands
Taken down to fill the gap from the increase in SP over last few days. It should bounce
It will bounce but will it today ?
Think by Friday you'll be glad you added more
I have
Whats happened to all the posters from the last 5 days ?
Buy some more you lot I’m losing money now so hurry up
Didn't mean to, nevermind !
Holding the 50ema 1H
https://invst.ly/11b15s
also at support on D
https://invst.ly/11b17j
SFU you've made him throw all of his toys out of his pram ! Ha ha !
Hahahahahahah belter.... Take it easy mate, GL.
No thanks I'm done here, been nice .
Chill out mate.. Why u getting so angry ? Was only an observation... Of course I want you to post wherever you like..
Stephen,
That's because it was ugly, nothing more. No need to read any more than that into it unless you only want posters that can see what the market is doing at times. I will be very happy to F off if you don't like it, no skin off my nose whether I post here or not and can certainly live without any PBB.
Perfect then :-)... Just you sounded worried with your "ugly" comment last night.
Stephen, I'm not worried, just looking at another buying opportunity fwiw
If you believe where this is going, dont worry about retracements.... Its all part and parcel of things.
Must be close to completing the FINN retracement soon?
Take a look here, target 10p, easy money to be made.
Guys, take a look at #PANR target £1 and currently 21p, easy money to be made 👍
Certainly going to go from strength to strength now after a big "wobblw".. More news to drop anytime reading through the RNS's !
This company is in the right place at the right time.
Acker
In a nutshell they use mathematical modelling and A.I to see how drugs in use and drugs in development will be effective in treating certain cancers, they have a range of over 70 clients and have proven track record in getting drugs through the various development phases which hitherto have been hit and miss wjrh average drug to marker taking 10 years and 90%failure rate with wasted spend of $$mlns
Q: What competitive advantage does Physiomics have?
That’s a great question. We have several. On the one hand, we are a specialist in oncology mathematical modelling, and there are few companies out there that can say that with their hand on heart. We have competitors that do mathematical modelling who tend to be generalists. We have competitors that focus on oncology, but they don’t tend to be specialists in modelling. So I believe the confluence of those two things is a position where we have a unique market opportunity. The second thing I would say is our people and our experience are really second to none. They work hard, they’re smart and they’re universally well respected by the clients that we take on. I also believe that we’re making genuinely important contributions to the R&D efforts of the clients that that we work with, and that has led to a significant boost in our reputation.
When I arrived at the Company 5-6 years ago, we were fairly little known other than amongst a small circle of clients that we’d been working with for a while. Now we’re getting referrals; people that we work with, talk to their friends and literally relatives sometimes, and we get phone calls from those individuals who may be working in in other companies. We’ve had several projects commissioned in this way, and this is extremely gratifying. I think it’s a real demonstration that what we do makes a difference and that our clients continue to value that.
They tweeted this yesterday which is a new & positive step for them, yes only a "news letter" but at least they are doing something proactive.
https://twitter.com/Physiomics/status/1699363223315607831?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet
Would be interesting to see what the ratio of signups are between those working in biotech and investors.
Amica, i believe Laura is doing a write up, so do not wish to step on their toes.
Re competition if you look at this site, it gives a few names https://craft.co/physiomics/competitors but i am not sure if they are correct!
SP is volatile imho because of it low shares in issue, and free float being really small. We have recently gone from 97m o 135m. It is also news driven, when news lands, be it good or bad, the SP can shift either way quickly.
You mentioned the drop, which one! We had a drop in Feb after CEO said there was some delays to contracts, however, Merckgroup have come back in to the fold, and i believe 1 of the delayed contracts was signed last week (125k)
The other big drop was its epic rise from 1p to 32p, and all the way back again over a period of time. From knowledge the company had to issue a RNS about the contract that was won and its price ( i think )
I am sure Laura will put more meat on the bones.